Agilent Technologies and Organon Teknika Announce Product Development and Distribution Agreement for Muscle Relaxation Monitoring Equipment.PALO ALTO, Calif. and BOXTEL, Netherlands--(BW HealthWire)-- Nov. 11, 1999-- Agilent Technologies, Inc., a subsidiary of Hewlett-Packard Company, and Organon or·ga·non or or·ga·num n. pl. or·ga·nons or or·ga·nums or or·ga·na 1. An organ. 2. A set of principles for use in scientific investigation. organon pl. organa [Gr.] organ. Teknika B.V. today announced the signing of a product development and distribution agreement covering the integration of Organon Teknika's TOF-Watch SX muscle relaxation technology with Agilent's Viridia 24/26 and Viridia CMS (1) See content management system and color management system. (2) (Conversational Monitor System) Software that provides interactive communications for IBM's VM operating system. series patient monitors. This agreement also allows Agilent to distribute the TOF-Watch SX product together with its patient monitoring systems in all countries of the European Union European Union (EU), name given since the ratification (Nov., 1993) of the Treaty of European Union, or Maastricht Treaty, to the European Community , as well as the Czech Republic, Hungary, Iceland, Norway, Poland, Russia, Switzerland and Turkey. TOF-Watch SX provides continuous monitoring of a patient's muscle relaxation under anesthesia, allowing anesthesia providers to carefully monitor and adjust the amount of relaxation drugs being delivered to the patient. Under the agreement, TOF-Watch SX will be modified specially to allow the appropriate interfacing with Agilent's Viridia patient monitors through an Agilent VueLink interface module. The patient's muscle relaxation status can be displayed and stored at the patient monitor, together with other respiratory and hemodynamic he·mo·dy·nam·ics n. (used with a sing. verb) The study of the forces involved in the circulation of blood. he information. Availability of this interface module is expected early next year. "This agreement underlines our commitment to the anesthesiology anesthesiology (ăn'ĭsthē'zēŏl`əjē), branch of medicine concerned primarily with procedures for rendering patients insensitive to pain, and for supporting life systems under the strains of anesthesia and surgery. community," said Dr. Jan Dopper, executive vice president of Organon Teknika. "Having pioneered the development of muscle relaxation monitoring equipment, it is our commercial strategy to make this new technology available as widely and as quickly as possible." "The addition of muscle relaxation monitoring into the Agilent portfolio is further proof of our commitment to anesthesia," said Tony Ecock, general manager of Agilent's Patient Monitoring Division. "It's also consistent with our strategy of investment protection, which allows the integration of such solutions into our current patient monitoring systems to be as seamless, simple and cost-effective as possible for our customers." About Organon Teknika Organon Teknika, a business unit of Akzo Nobel with headquarters in Boxtel, the Netherlands, specializes in research and development, manufacturing and marketing of advanced systems for hospitals, laboratories and blood banks. The company currently employs more than 2,200 people and is active in more than sixty countries worldwide. Organon Teknika has a strong track record of innovation, both in the field of diagnostic products and in the field of products for the management of the neuromuscular neuromuscular /neu·ro·mus·cu·lar/ (-mus´ku-ler) pertaining to nerves and muscles, or to the relationship between them. neu·ro·mus·cu·lar adj. 1. block. The company introduced the first clinically successful non-depolarizing muscle relaxant muscle relaxant an agent that specifically aids in reducing muscle tone. Most such agents inhibit the transmission of nerve impulses at the somatic neuromuscular junctions. They include tubocurarine, gallamine, pancuronium, succinylcholine and decamethonium bromide. Pavulon(R) in 1973. In 1983 the company introduced Norcuron(R), which soon became the gold standard of products for neuromuscular block, because of its excellent safety profile. In 1994, Organon Teknika introduced the first rapid onset non-depolarizing neuromuscular blocking agent neuromuscular blocking agent n. Any of various compounds, such as curare, that compete with neurotransmitters for nerve cell receptor sites, thus preventing the contraction of skeletal muscles. Zemuron(R) / Esmeron(R), which is today the most widely used muscle relaxant in the world. The company introduced Raplon(R), a new rapid onset short duration muscle relaxant in October 1999. In 1993 Organon Teknika introduced TOF-GUARD(R), the first objective neuromuscular monitoring device, based on accelometric technology. In 1997 TOF-Watch(R) was introduced, a more user-friendly device, better adapted to daily clinical needs. In 1999 TOF-Watch(R) S, for use in the intensive care unit, was launched. More information on Organon Teknika can be found on the World Wide Web at: http://www.organonteknika.com. About Akzo Nobel Akzo Nobel services customers throughout the world with healthcare products, coatings, chemicals and fibers. The company currently employs approximately 83,000 people in almost seventy countries. Consolidated sales for 1998 totaled EUR EUR In currencies, this is the abbreviation for the Euro. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 12.5 billion (NLG NLG The ISO 4217 currency code for the Dutch Guilder. 27.5 billion, USD USD In currencies, this is the abbreviation for the U.S. Dollar. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 13.8 billion, GBP GBP In currencies, this is the abbreviation for the British Pound. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 8.4 billion). About Agilent's Healthcare Solutions Group Agilent's Healthcare Solutions Group is a worldwide leader in electro-medical clinical measurement and diagnostic solutions for the healthcare industry. The group has 5,000 employees and had revenues of more than $1.3 billion in its 1998 fiscal year. Agilent holds leading market share worldwide in patient monitoring, cardiovascular ultrasound imaging and for critical-care information-management systems. Information about Agilent's Healthcare Solutions Group can be found on the Web at http://www.agilent.com/healthcare/. About Agilent Technologies Agilent Technologies, Inc. is a diversified technology company, resulting from Hewlett-Packard Company's plan to strategically realign re·a·lign tr.v. re·a·ligned, re·a·lign·ing, re·a·ligns 1. To put back into proper order or alignment. 2. To make new groupings of or working arrangements between. itself into two fully independent companies. With 43,000 employees serving customers in more than 120 countries, Agilent Technologies, as a subsidiary of HP, is a global leader in designing and manufacturing test, measurement and monitoring instruments, systems and solutions, and semiconductor and optical components. The company serves markets that include communications, electronics, life sciences and healthcare. The businesses comprising Agilent had net revenues of nearly $8 billion in fiscal year 1998. Information about Agilent Technologies can be found on the Web at http://www.agilent.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion